All In Biotech

Free tool

Medicare drug spending

CMS's Spending by Drug data: what Medicare paid for each drug before manufacturer rebates. Part D covers drugs dispensed by pharmacies; Part B covers drugs given in a doctor's office or hospital outpatient department. Commercial and list prices are not public data and are not shown.

Last checked: Nov 20, 2026Latest source record: 2024 calendar yearSource: CMS (Medicare Part D Spending by Drug : 2024-01-01; Medicare Part B Spending by Drug : 2024-01-01)Methods & limitations

Part D, 2024

$288.7B

Gross drug spending in the dataset

Part B, 2024

$60.8B

Gross drug spending in the dataset

Drugs listed

8

Part D and Part B

Total spending by year

  • Part D
  • Part B
View as table
YearPart DPart B
2020$194,092,038,339$37,778,829,680
2021$213,513,349,361$40,135,340,775
2022$239,779,215,689$44,241,259,745
2023$275,808,918,753$50,775,853,083
2024$288,667,842,058$60,838,164,403
Reset

Top 8 by total spending

2024 figures. Growth compares with 2023. Per-beneficiary ranks skip drugs with fewer than 11 beneficiaries.

DrugPartSpendingChangeBeneficiariesPer beneficiaryPer unit
Methotrexate*

Methotrexate Sodium

D$57.2M-30%551,528$104$0.63
Rasuvo

Methotrexate/PF

D$22.5M+8%5,475$4,107$367.06
Otrexup

Methotrexate/PF

D$7.5M-7%1,385$5,446$452.61
Trexall

Methotrexate Sodium

D$2.3M+10%1,987$1,168$41.74
Methotrexate Sodium

Methotrexate Sodium/PF

D$901K+7%18,556$49$1.50
Xatmep

Methotrexate

D$246K-1%84$2,934$19.76
Methotrexate (J9260)*

Methotrexate Sodium* · J9260

B$104K+115%4,458$23$2.35
Methotrexate (J8610)*

Methotrexate Sodium* · J8610

B$4K-17%115$31$0.24

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.